A major breakthrough in cancer research is arising with the use of mini-antibodies to re-engage mutated p53. This essential malignant suppressor protein is frequently inactivated in many forms of tumors, resulting https://redhotbookmarks.com/story21889638/mini-antibodies-reactivate-tumor-suppressor-p53-a-promising-approach-for-malignant-therapy